Paradigm Biopharmaceuticals | PAR - Selling And Administration Expenses

Stock Price
0.26
Daily Change
0 0%
Monthly
-11.86%
Yearly
-38.82%
Q1 Forecast
0.25

Paradigm Biopharmaceuticals reported AUD1.61M in Selling and Administration Expenses for its fiscal semester ending in June of 2025.





Selling And Administration Expenses Change Date
Avita Medical AUD 19.03M 1.95M Dec/2025
Medical Developments International AUD 2.84M 4.19M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Pacific Edge NZD 19.17M 1.32M Dec/2025
PYC Therapeutics AUD 328.4K 1.8M Dec/2025
Telix Pharmaceuticals AUD 93.48M 1.04M Dec/2025